WallStSmart
GLTO

Galecto Inc

NASDAQ: GLTO · HEALTHCARE · BIOTECHNOLOGY

$25.66
+7.23% today

Updated 2026-04-30

Market cap
$43.73M
P/E ratio
P/S ratio
EPS (TTM)
$-12.11
Dividend yield
52W range
$2 – $38
Volume
0.3M

WallStSmart proprietary scores

16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target
$32.00
+24.71%
12-Month target
Intrinsic (DCF)
Margin of safety
0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-2.62M

Key financials

Revenue Net Income Free Cash Flow
Metric2021202220232024TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-51.75M$-61.62M$-38.35M$-21.44M$-3.13M
EPS$-12.11
Free cash flow$-52.53M$-43.13M$-36.99M$-18.62M$-2.62M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
GLTO$43.73M164.33.05.05.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Galecto Inc trades at $25.66. Our Smart Value Score of 16/100 indicates the stock is weak.

Frequently asked questions

What is Galecto Inc's stock price?
Galecto Inc (GLTO) trades at $25.66.
Is Galecto Inc overvalued?
Smart Value Score 16/100 (Grade F, Strong Sell).
What is the price target of Galecto Inc (GLTO)?
The analyst target price is $32.00, representing +24.7% upside from the current price of $25.66.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-1.10%
Beta1.41
50D MA$12.85
200D MA$5.73
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.3M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years